RT Journal Article
SR Electronic
T1 CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 97
OP 120
DO 10.3899/jrheum.150376
VO 43
IS 1
A1 Lucy McGeoch
A1 Marinka Twilt
A1 Leilani Famorca
A1 Volodko Bakowsky
A1 Lillian Barra
A1 Susan M. Benseler
A1 David A. Cabral
A1 Simon Carette
A1 Gerald P. Cox
A1 Navjot Dhindsa
A1 Christine S. Dipchand
A1 Aurore Fifi-Mah
A1 Michelle Goulet
A1 Nader Khalidi
A1 Majed M. Khraishi
A1 Patrick Liang
A1 Nataliya Milman
A1 Christian A. Pineau
A1 Heather N. Reich
A1 Nooshin Samadi
A1 Kam Shojania
A1 Regina Taylor-Gjevre
A1 Tanveer E. Towheed
A1 Judith Trudeau
A1 Michael Walsh
A1 Elaine Yacyshyn
A1 Christian Pagnoux
A1 for The Canadian Vasculitis Research Network
YR 2016
UL http://www.jrheum.org/content/43/1/97.abstract
AB Objective. The Canadian Vasculitis research network (CanVasc) is composed of physicians from different medical specialties and researchers with expertise in vasculitis. One of its aims is to develop recommendations for the diagnosis and management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) in Canada.Methods. Diagnostic and therapeutic questions were developed based on the results of a national needs assessment survey. A systematic review of existing non-Canadian recommendations and guidelines for the diagnosis and management of AAV and studies of AAV published after the 2009 European League Against Rheumatism/European Vasculitis Society recommendations (publication date: January 2009) until November 2014 was performed in the Medline database, Cochrane library, and main vasculitis conference proceedings. Quality of supporting evidence for each therapeutic recommendation was graded. The full working group as well as additional reviewers, including patients, reviewed the developed therapeutic recommendations and nontherapeutic statements using a modified 2-step Delphi technique and through discussion to reach consensus.Results. Nineteen recommendations and 17 statements addressing general AAV diagnosis and management were developed, as well as appendices for practical use, for rheumatologists, nephrologists, respirologists, general internists, and all other healthcare professionals more occasionally involved in the management of patients with AAV in community and academic practice settings.Conclusion. These recommendations were developed based on a synthesis of existing international guidelines, other published supporting evidence, and expert consensus considering the Canadian healthcare context, with the intention of promoting best practices and improving healthcare delivery for patients with AAV.